All Model Pty Ltd is developing novel compounds for vision cycle disorders — Leber Congenital Amaurosis, Stargardt disease, and Retinitis Pigmentosa. Our compounds are at research stage and are intended for surgical use only; they are not currently available as a treatment and are not for self-administration.
If you, or someone close to you, has been diagnosed with one of these conditions, this registry helps us identify how many people the compound could eventually serve, and lets us notify you when clinical-trial recruitment opens.